The results suggest that miR‐141 targets Cbl‐b and c‐Cbl to prevent TRAF2‐mediated polyubiquitination and degradation of caspase‐8, and thus increases TRAIL sensitivity in gastric cancer cells. The gene discussed is TRAF2; the disease is gastric cancer.